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Dear Editor:
Liver metastasis in patients with colorectal cancer is not
uncommon. Synchronous liver metastasis can be detected
in 15–25% of the patient population. Metachronous liver
metastasis can happen in 40–50% of the patients who have
received surgery for its primary cancer. With the advance-
ment of laparoscopic colorectal surgery, most of the patient
are now receiving curative resection by minimally invasive
approach resulting in an early recovery and virtually
invisible wound. However, laparoscopic liver resection
and ablation for liver metastasis still have their limitations.
Major hepatectomy by laparoscopic means is feasible, but it
still requires a large incision for specimen delivery.
Laparoscopic radiofrequency ablation can tackle most of
the tumour in the liver, but ablating a tumour at the dome of
the liver or lesion near the inferior vena cava can be
technically difficult if not impossible. High intensive
focused ultrasound (HIFU) is a relatively new technique
and is a totally extracorporeal non-invasive ablative
treatment method using focused ultrasound energy that is
capable of producing coagulation necrosis of the targeted
HCC via intact skin without the need of surgical incision. It
can reach all parts of the liver as long as the lesion can be
localised by the ultrasound.
A 53-year-old patient who presented with left side
abdominal pain for 3 months was admitted to our hospital.
Complete blood picture showed that his haemoglobin level
was 10 g/dL. Colonscopy showed a circumferential tumour
at the descending part of the colon. Biopsy of the lesion
showed adenocarcinoma of the colon. PET/CTscan showed
a tumour at the descending part of the colon which is 18-
FDG avid. In addition, there was an 8-cm tumour at section
4 and 8 of the liver abutting in the major hepatic vein and
IVC which was also 18-FDG avid. In view of the
impending large bowel obstruction, laparoscopic left hemi-
colectomy was performed using four operating ports. The
operation time was 2 h and 44 min, and the blood loss was
50 mL. During laparoscopy, the surgeon assessed the liver
metastasis that had involved about 25% of the total liver
volume. The final pathology of the resected colon showed
poorly differentiated mucinous adenocarcinoma with inva-
sion to the serosa. Fourteen lymph nodes were examined
and 5 showed tumour metastases.
As surgical treatment is technically not feasible for the
liver metastasis, chemotherapy was commenced as an
adjunct for the patient. In total 7 cycles of FOLFOX was
administrated, and the tumour was responding well to the
chemotherapy. Reassessment CT scan showed that the
tumour had reduced to 2 cm in size but in close proximity
to the middle hepatic vein and the heart.
As patient preferred non-invasive management for the
residual disease, HIFU was selected as an alternative
ablative treatment for of the liver metastasis under general
anesthesia. HIFU ablation was carried out using the JC
HIFU system (Chongqing Haifu Technology, Chongqing,
China). The ablation was performed using real-time
ultrasound image guidance. The system comprised of a
real time diagnostic imaging unit which provides direct
visualization of the tumour, a therapeutic unit which
consisted of a ultrasound energy transducer which can
effectively converge the ultrasound energy at a 12-cm focal
point, a degassed water circulation unit which provide a
medium for ultrasound transmission outside the body and a
computer system which integrated the above-named device
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operation at 0.8 MHz. The target lesion was localized using a
3.6-MHz diagnostic ultrasound probe (Phillips), which is
incorporated at the centre of the treatment transducer.
Artificial right pleural effusion was induced before treatment
in order to facilitate the transmission of ultrasound wave and
prevent reflection from the lung parenchyma. Parallel slides
of the target tumour with 5 mm separation including a 1-cm
margin of the tumour were planned. In total 458,000 J of
energy was transferred to the lesion with satisfactory grey
scale change observed during the treatment which signified
coagulation necrosis of the tumour lesion. The artificial right
pleural effusion did not require drainage, and the patient was
discharged on day 3 after HIFU therapy. Post-operative
contrast CT scan showed complete ablation of the tumour
lesion with no residual disease in the liver.
Modern management of colorectal cancer involved a
multidisciplinary team in order to simplify treatment work-
flow on a complicated disease entity. In this patient,
treatment was separated into laparoscopic colonic resection
for the primary lesion which was going to cause bowel
obstruction, effective chemotherapy which successfully
downgraded the tumour to surgically manageable lesion
and HIFU ablation to the residual tumour at a difficult
position. Since the liver metastasis was near the hepatic
vein origin and which was close to the heart, laparoscopic
and percutaneous RFA would not be possible. Surgical
resection provided one of the best oncological clearances
but the price to pay would be a big surgical incision for a
2 cm tumour.
Among all type of minimally invasive therapy for liver
tumour, HIFU is the only technique to be completely
extracorporeal, through the use of nonionizing energy. As a
non-invasive technique, HIFU is receiving increasing
interest in the management of liver cancer. Originally, many
a studies were only conducted in China, HIFU has been
gaining its popularity across the world with its non-invasive
nature. It achieves coagulation necrosis by means of
thermal ablative effect where energy is built up in the
tissue via the ultrasound propagation; the cavatation effect
which causes rapid expansion of the particles along the
focused point of the ultrasound transmission; and last but
not least it causes tumour vessel thrombosis for vessel
smaller around 2 mm in size. It has been reported that
HIFU can achieve complete tumour necrosis even when the
lesion is located closely to the major hepatic vessel where
high volume flow is anticipated. There will be less heat sink
effect as compared to RFA as the thermal precipitation is
from each focused ablation but not from heat conduction of
an instrument. There is no irreversible damage to major
vessels even though the adjacent tumour had been
completely ablated. In this patient, complete liver tumour
ablation was achieved with no surgical incision required
and no complication was observed. In early studies, the
complications of HIFU were mainly related to subcutane-
ous tissue injuries where the energy precipitated in the
ultrasound beam pathway to the lesion. Clinical manifes-
tations of subcutaneous injury include mild pain, skin
oedema or even skin burn. Most of the complications were
self limiting and did not require further intervention or
treatment. Thermal injury to adjacent organ may occur as
focused ultrasound heat may spread to surrounding area by
diffusion. We had paid particular attention to the boarder of
the heart as the targeted lesion was closely located.
Ventilation control by the anaesthesiologist by halting
respiratory movement had greatly reduced the undesirable
movement of the diaphragm. Ultrasound beam might have
passed through the beating heart during the procedure but
as long as the focused point was staying away from the
heart, no injury to the myocardium was observed.
HIFU is a totally non invasive ablative treatment
modality. It produces mechanical destruction to the tumour
by means of coagulation necrosis. It is a safe alternative
treatment option for liver metastasis particular when the
tumour is located in difficult location and when minimally
invasive approach is desired.
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